ProQR Therapeutics N.V. Banner Image

ProQR Therapeutics N.V. has reached its limit for free report views

Work for ProQR Therapeutics N.V.? Upgrade Your Profile and unlock all your annual reports.

ProQR Therapeutics N.V.

  • Ticker PRQR
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
ProQR Therapeutics N.V. Logo Image
  • 51-200 Employees
  • Based in Leiden, Netherlands
ProQR Therapeutics is dedicated to changing lives through the creation of transformative RNA therapies for the treatment of genetic eye diseases such as Leber congenital amaurosis 10, Usher syndrome and autosomal dominant retinitis pigmentosa. Based on their unique proprietary RNA repair platform technologies they are growing their pipeline with patients and loved ones in mind.
ProQR Therapeutics N.V.

Most Recent Annual Report

ProQR Therapeutics N.V. MOST RECENT 2019 Annual Report

Report Locked. ProQR Therapeutics N.V. has reached its limit for free report views.

Older/Archived Annual Reports